questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of targeted treatments for invasive lobular breast cancer compared with other forms of breast cancer.
answerText: The National Institute for Care Excellence (NICE) assesses new breast cancer medicines based on how well they work and whether they are good value for money. In doing so, it usually looks at factors such as the stage of the cancer and whether it has parti...
heading: Breast Cancer